The efficacy and safety of heattherapy and coldtherapy in the treatment of wart
Not Applicable
- Conditions
- wart.B07
- Registration Number
- IRCT2015010120514N1
- Lead Sponsor
- Vice Chancellor for Reasearch of Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
age of 18 years old and above; less than 10 warts; signed informed consent voluntarily and knowingly. Exclusion criteria: being treated during the last two months; warts on the face and genital; plane warts; pregnancy; breast feeding; intolerance to heat; intolerance to cold; diabetes mellitus; peripheral vascular disease; immunodeficiency.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disappearing of wart. Timepoint: Before the intervention, every month in thermotherapy group after discontinuation of tretment for three month and in cryotherapy group before the intervention and every two weeks for the maximum six sessions and then 3 months after the discontinuation of treatment. Method of measurement: physical examination, Digital photography, patient's satisfaction.
- Secondary Outcome Measures
Name Time Method Blister. Timepoint: After each session of intervention. Method of measurement: Asking patients.;Ulcer. Timepoint: After each session of intervention. Method of measurement: Asking patients.;Infection. Timepoint: After each session of intervention. Method of measurement: Asking patients.